ABN Amro Group NV (ABN)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 38.81 |
|---|---|
| 52-week range | 24.49 – 44.22 |
| Return, 1 month / 3 months | −10.5% / +3.0% |
| Return, 1 year / 3 years | +65.4% / +280.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 35 |
| Volatility (1 year) | 27.6% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 74.41M EUR |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ABN AMRO is a Dutch bank based in Amsterdam that provides banking services to retail customers, private clients and businesses. Its retail arm offers current accounts, savings, mortgages, loans and payment services, while its private banking business serves wealthy individuals and its corporate banking division works with companies and institutions. The bank operates mainly in the Netherlands and also has activities in neighbouring countries and selected international markets, offering lending, transaction banking and wealth management.
On this site ABN Amro Group NV appears as a stock on the Euronext Amsterdam (Netherlands), code ABN, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ABN Amro Group NV (ABN) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 38.81 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 6 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 65.4% and over the last three months it rose 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.9% | ||
| From 52-week high | -11.7% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.0% | ||
| 6-month return | 36.7% | ||
| 12-month return, skipping the last month | 84.8% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 74.41M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.5% |
|---|---|
| 1 month | −10.5% |
| 3 months | +3.0% |
| 6 months | +36.7% |
| 1 year | +65.4% |
| 3 years | +280.0% |
| 5 years | +344.6% |
Signals
| 50-day / 200-day average | 41.87 / 34.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | EUR 0.6800 |
| 24 Apr 2026 | EUR 1.0048 |
| 13 Aug 2025 | EUR 0.5400 |
| 25 Apr 2025 | EUR 0.7500 |
| 14 Aug 2024 | EUR 0.6000 |
| 26 Apr 2024 | EUR 0.8900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.